portal
  Home About us Reports Charts News Custom Company Scan  
Report Charts News
*
Title Content
Economy&Goods
  Economy
  ConsumerGoods
  Food&Beverage
  Agriculture
Life Sciences
  Biotechnology
  Medical
  Pharmaceutical
Manufacturing
  Automotive
  Chemical
  Energy
  Machinery
  Material
  Metals & Minerals
Public Sector
  Environment
  Finance Service
  Infrastructure
  Logistics
  Real Estate
  Retailing
  Tourism
  Training
Technology And Media
  Electronics
  Internet
  Hardware
  Media
  Software
  Telecommunications

Tel: 0086-10-82600828
Fax: 0086-10-82601570
Email:


 Beijing SL Pharmaceutical invested PnuVax and entered into high-end vaccine market
 
CreateTime:2011-09-08     Source:ResearchInChina Editor:hangmei
Text Size:       
 
Beijing SL Pharmaceutical announced on 13th Aug, that it will invest RMB130 million to set up joint-venture PnuVax SL with Canadian company PnuVax Incorporated. SL Pharmaceutical and PnuVax will ho...
Forget password? get password
Welcome to our website.
This service is open to member only.

Contact our customer service team
Tel: 86-10-82600828, 82600893
Fax: 86-10-82601570
Email: report@researchinchina.com

Related Reports
China Heparin Industry Report, 2014-2017
Global and China Monoclonal Antibody Industry Report, 2014-2019
Global and China DNA Sequencing Industry Research Report, 2014...
Global and China Stem Cell Industry Report, 2014-2017
China Human Vaccine Industry Report, 2014-2017
2005-2010 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1